Search results for "Digest"

showing 10 items of 3038 documents

The Impact of Antiviral Therapy and the Influence of Metabolic Cofactors on the Outcome of Chronic HCV Infection

2010

Natural history of HCV related chronic hepatitis is influenced and modified by many factors: virus features, coinfections and host characteristics. In particular, a peculiar genetic background of the host by conditioning the occurrence of intracellular metabolic derangements (i.e., insulin resistance) might contribute to accelerate the rate of progression to cirrhosis and eventually the occurrence of hepatocellular carcinoma (HCC) and death. Likely, direct interplays between virus genotype and host genetic background might be hypothesized at this level. Morbidity and mortality in cirrhosis is primarily associated with complications of liver cirrhosis (ascites, hepatic encephalopathy, jaundi…

CirrhosisHepatologybusiness.industryReview ArticleJaundicemedicine.diseaseVirusdigestive system diseasesHCV therapy natural historyInsulin resistanceInterferonHepatocellular carcinomaImmunologyAscitesmedicinelcsh:Diseases of the digestive system. Gastroenterologymedicine.symptomlcsh:RC799-869businessHepatic encephalopathymedicine.drugInternational Journal of Hepatology
researchProduct

Hepatitis C virus (HCV) infection: a systemic disease.

2007

Abstract Hepatitis C virus (HCV) infection is a global health problem, being the second most common chronic viral infection in the world with a global prevalence of about 3% (about 180 million people). HCV is both an hepatotropic and a lymphotropic virus; and chronic infection could cause, on one hand, chronic hepatitis, cirrhosis and hepatocellular carcinoma and on the other hand several extrahepatic diseases including, first, mixed cryoglobulinemia and lymphoma. The association between hepatic (hepatocellular carcinoma) and extrahepatic (lymphoma, thyroid cancer) malignancies has justified the inclusion of HCV among human cancer viruses. The pathogenesis of HCV-related sequelae (hepatic o…

CirrhosisLymphomaHepatitis C virusClinical BiochemistryLymphoproliferative disordersHepacivirusmedicine.disease_causeBiochemistryModels BiologicalViruschemistry.chemical_compoundPegylated interferonmedicineHumansMolecular Biologybusiness.industryRibavirinGeneral MedicineHepatitis C Chronicmedicine.diseasedigestive system diseasesChronic infectionchemistryCryoglobulinemiaHepatocellular carcinomaImmunologyMolecular Medicinebusinessmedicine.drug
researchProduct

The Evolving Role of Fetuin-A in Nonalcoholic Fatty Liver Disease: An Overview from Liver to the Heart

2021

Nonalcoholic fatty liver disease (NAFLD) is strongly associated to the features of metabolic syndrome which can progress to cirrhosis, liver failure and hepatocellular carcinoma. However, the most common cause of mortality in people with NAFLD is not liver-related but stems from atherosclerotic cardiovascular disease (CVD). The prevalence of NAFLD is on the rise, mainly as a consequence of its close association with two major worldwide epidemics, obesity and type 2 diabetes (T2D). The exact pathogenesis of NAFLD and especially the mechanisms leading to disease progression and CVD have not been completely elucidated. Human fetuin-A (alpha-2-Heremans Schmid glycoprotein), a glycoprotein produ…

Cirrhosisalpha-2-HS-GlycoproteinQH301-705.5030209 endocrinology & metabolismReviewType 2 diabetes030204 cardiovascular system & hematologyBioinformaticsdigestive systemCatalysisInorganic ChemistryPathogenesis03 medical and health sciences0302 clinical medicineInsulin resistanceNon-alcoholic Fatty Liver DiseaseNAFLDNonalcoholic fatty liver diseaseAnimalsHumansMedicineBiology (General)Physical and Theoretical ChemistryQD1-999Molecular BiologyCVD Fetuin‐A NAFLD Animals Cardiovascular Diseases Fibrosis Humans Liver Non-alcoholic Fatty Liver Disease alpha-2-HS-GlycoproteinSpectroscopybusiness.industryOrganic Chemistrynutritional and metabolic diseasesGeneral MedicineCVDmedicine.diseaseFibrosisObesitydigestive system diseasesFetuin-AComputer Science ApplicationsChemistryLiverCardiovascular DiseasesHepatocellular carcinomaMetabolic syndromebusinessInternational Journal of Molecular Sciences
researchProduct

Gender differences in chronic HBsAg carriers in Italy: Evidence for the independent role of male sex in severity of liver disease

2015

It has been shown that sexual hormones have an opposite effect on hepatic fibrosis progression and hepatocellular carcinoma development. Sex differences among 2,762 chronic HBsAg carriers consecutively referring Italian hospitals in 2001 and in 2007 have been evaluated, particularly focusing on the role of gender on severity of liver disease. The overall sex ratio (males/females) was 2.6. Females were more likely born abroad and new diagnosis cases; but less likely HIV coinfected. No sex difference was observed regarding coinfection with other hepatitis viruses. The sex ratio linearly increased with increasing severity of liver disease, being 1.3 in normal ALT, 2.8 in chronic hepatitis, 3.6…

Cirrhosisbusiness.industryHepatitis Bmedicine.diseaseVirologydigestive system diseasesVirusLiver diseaseInfectious DiseasesVirologyHepatocellular carcinomamedicineCoinfectionHepatic fibrosisbusinessSex ratioJournal of Medical Virology
researchProduct

Sicilian potential biogas production from Citrus industry by-product

2017

In Europe, Italy is the second nation after Spain in Citrus production and 49% ca. of national fruit production is located in Sicily. The by-product obtained from the industrial processing of Citrus fruits into juice and essential oils is called “pastazzo” or Citrus Waste (CW). This study is aimed at evaluating the Sicilian potential biogas and energy production from the above “pastazzo” and verifying the possibility of using this by-product for Anaerobic Digestion (AD) process within 30 km from processing plants. The areas cultivated with Citrus species in Sicily and their distribution in the various municipal districts were mapped and analysed by means of QGIS software, together with the …

Citrus industry Anaerobic Digestion biogas energy.Settore AGR/09 - Meccanica Agraria
researchProduct

Influence of orange cultivar and mandarin postharvest storage on polyphenols, ascorbic acid and antioxidant activity during gastrointestinal digestio…

2017

Polyphenols, ascorbic acid content and antioxidant activity of two sweet oranges (Navel-N and Cara Cara-CC) and mandarin (Clementine-M) as well as their bioaccessibilities were evaluated in pulps and compared to those in fresh juice. Thus, pulps of oranges and mandarins displayed higher hesperidin (HES), narirutin (NAR), total flavonoids (TF), total phenols (TP) and antioxidant activity (AAC) than their corresponding juices. Also, CC products presented higher bioactive compounds content than N ones. Bioaccessibility of bioactive compounds and AAC were higher in pulps of both oranges and mandarin than in their corresponding juices. Oranges (N and CC) pulps and juices presented higher bioacce…

CitrusAntioxidantTotal antioxidant activitymedicine.medical_treatmentIn vitro gastrointestinal digestionCitrus fruitsOrange (colour)Ascorbic Acid01 natural sciencesAntioxidantsAnalytical ChemistryHesperidinchemistry.chemical_compound0404 agricultural biotechnologystomatognathic systemmedicineFood sciencePhenolsFlavonoidsNarirutin010401 analytical chemistryPolyphenols04 agricultural and veterinary sciencesGeneral MedicineAscorbic acid040401 food science0104 chemical scienceschemistryFood StoragePolyphenolFruitPostharvestAscorbic acidOxidation-ReductionFood ScienceFood chemistry
researchProduct

Energy regulatory signals and food reward.

2009

The hormones insulin, leptin, and ghrelin have been demonstrated to act in the central nervous system (CNS) as regulators of energy homeostasis, acting at medial hypothalamic sites. Here, we summarize research demonstrating that, in addition to direct homeostatic actions at the hypothalamus, CNS circuitry that subserves reward and is also a direct and indirect target for the action of these endocrine regulators of energy homeostasis. Specifically, insulin and leptin can decrease food reward behaviors and modulate the function of neurotransmitter systems and neural circuitry that mediate food reward, the midbrain dopamine (DA) and opioidergic pathways. Ghrelin can increase food reward behavi…

Clinical BiochemistryCentral nervous systemDiet and obesityToxicologyBiochemistryEnergy homeostasisArticleBehavioral NeuroscienceRewardDopaminemedicineAnimalsHomeostasisHumansOvereatingBiological PsychiatryPharmacologyLeptindigestive oral and skin physiologyBrainFeeding Behaviormedicine.anatomical_structureHypothalamusFoodGhrelinNerve NetPsychologyEnergy MetabolismNeurosciencemedicine.drugPharmacology, biochemistry, and behavior
researchProduct

Comparison of several methods used for the determination of cephalosporins. Analysis of cephalexin in pharmaceutical samples

2002

The precision of UV absorbance of intact and acid degraded cephalosporins, ninhydrin, high performance liquid chromatography and iodometric methods used for analysis of cefoxitin, cefotaxime, cephazolin and cephalexin were compared. To obtain the calibration graphs the analytical signal used were: absorbance, first derivative absorbance, second derivative absorbance and H-point Standard Additions Method by using absorbance values at two selected wavelengths as analytical signal. These methods and calibration graphs were also used for the determination of cephalexin in pharmaceutical samples.

Clinical BiochemistryPharmaceutical ScienceCapsulesHigh-performance liquid chromatographyAnalytical ChemistryAbsorbancechemistry.chemical_compoundIodometrySpectrophotometryDrug Discoverypolycyclic compoundsmedicineChromatography High Pressure LiquidSpectroscopyAntibacterial agentSecond derivativeCephalexinChromatographymedicine.diagnostic_testChemistrydigestive oral and skin physiologyTitrimetryNinhydrinCephalosporinsSolutionsStandard additionNinhydrinIndicators and ReagentsSpectrophotometry UltravioletJournal of Pharmaceutical and Biomedical Analysis
researchProduct

Factors influencing inclusion in digestive cancer clinical trials: A population-based study

2015

Inclusion in a randomized therapeutic trial represents an optimal therapeutic strategy.To determine the influence of demographic characteristics and deprivation on the enrolment of patients in digestive cancer clinical trials.Between 2004 and 2010, 4632 patients were recorded by the Burgundy Digestive Cancer Registry. According to a balancing score, the 136 patients included in a clinical trial were matched with 272 patients who met the eligibility criteria for trials. Deprivation was measured by the ecological European deprivation index. A conditional multivariate logistic regression was performed.Patients aged over 75 years were significantly less likely to be included in clinical trials …

Clinical Trials as TopicPediatricsmedicine.medical_specialtyMultivariate analysisHepatologybusiness.industryPatient SelectionAge FactorsGastroenterologyOdds ratioLogistic regressionClinical trialPopulation based studyLogistic ModelsSocioeconomic FactorsMultivariate AnalysismedicineHumansRegistriesbusinessInclusion (education)Digestive cancerGastrointestinal NeoplasmsTherapeutic strategyDigestive and Liver Disease
researchProduct

Fighting the bushfire in HCC trials

2011

Clinical Trials as TopicText miningCarcinoma HepatocellularHepatologybusiness.industryBiopsyLiver NeoplasmsMedicineHumansbusinessData sciencedigestive system diseasesJournal of Hepatology
researchProduct